Artykuły w czasopismach na temat „Mutation”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Mutation”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
GARCÍA-DORADO, A., C. LÓPEZ-FANJUL i A. CABALLERO. "Properties of spontaneous mutations affecting quantitative traits". Genetical Research 74, nr 3 (grudzień 1999): 341–50. http://dx.doi.org/10.1017/s0016672399004206.
Pełny tekst źródłaEllis, Nathan A. "Mutation-causing mutations". Nature 381, nr 6578 (maj 1996): 110–11. http://dx.doi.org/10.1038/381110a0.
Pełny tekst źródłaMatsutani, Taro, Yuki Ueno, Tsukasa Fukunaga i Michiaki Hamada. "Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference". Bioinformatics 35, nr 22 (16.04.2019): 4543–52. http://dx.doi.org/10.1093/bioinformatics/btz266.
Pełny tekst źródłaLee, Joon-Hyop, Jiyoung Ahn, Won Seo Park, Eun Kyung Choe, Eunyoung Kim, Rumi Shin, Seung Chul Heo i in. "Colorectal Cancer Prognosis is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study". Journal of Clinical Medicine 8, nr 1 (17.01.2019): 111. http://dx.doi.org/10.3390/jcm8010111.
Pełny tekst źródłaBustamante, A. V., A. M. Sanso, D. O. Segura, A. E. Parma i P. M. A. Lucchesi. "Dynamic of Mutational Events in Variable Number Tandem Repeats ofEscherichia coliO157:H7". BioMed Research International 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/390354.
Pełny tekst źródłaPawlik, Timothy M., Darrell R. Borger, Yuhree Kim, David Cosgrove, Sorin Alexandrescu, Ryan Thomas Groeschl, Vikram Deshpande i in. "Genomic profiling of intrahepatic cholangiocarcinoma: Refining prognostic determinants and identifying therapeutic targets." Journal of Clinical Oncology 32, nr 3_suppl (20.01.2014): 210. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.210.
Pełny tekst źródłaRobinson, Philip S., Tim H. H. Coorens, Claire Palles, Emily Mitchell, Federico Abascal, Sigurgeir Olafsson, Bernard C. H. Lee i in. "Increased somatic mutation burdens in normal human cells due to defective DNA polymerases". Nature Genetics 53, nr 10 (30.09.2021): 1434–42. http://dx.doi.org/10.1038/s41588-021-00930-y.
Pełny tekst źródłaTrindade, Sandra, Lilia Perfeito i Isabel Gordo. "Rate and effects of spontaneous mutations that affect fitness in mutator Escherichia coli". Philosophical Transactions of the Royal Society B: Biological Sciences 365, nr 1544 (27.04.2010): 1177–86. http://dx.doi.org/10.1098/rstb.2009.0287.
Pełny tekst źródłaWatters, M. K., i D. R. Stadler. "Spontaneous mutation during the sexual cycle of Neurospora crassa." Genetics 139, nr 1 (1.01.1995): 137–45. http://dx.doi.org/10.1093/genetics/139.1.137.
Pełny tekst źródłaLee, Seung-Shin, Jae-Sook Ahn, Taehyung Kim, Hyeoung Joon Kim, Yeo-Kyeoung Kim, Seo-Yeon Ahn, Sung-Hoon Jung i in. "RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis". Blood 128, nr 22 (2.12.2016): 5253. http://dx.doi.org/10.1182/blood.v128.22.5253.5253.
Pełny tekst źródłaWayne, Marta L., i Trudy F. C. Mackay. "Quantitative Genetics of Ovariole Number in Drosophila melanogaster. II. Mutational Variation and Genotype-Environment Interaction". Genetics 148, nr 1 (1.01.1998): 201–10. http://dx.doi.org/10.1093/genetics/148.1.201.
Pełny tekst źródłaPálinkás, Hajnalka Laura, Lőrinc Pongor, Máté Balajti, Ádám Nagy, Kinga Nagy, Angéla Békési, Giampaolo Bianchini, Beáta G. Vértessy i Balázs Győrffy. "Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer". International Journal of Molecular Sciences 23, nr 2 (6.01.2022): 633. http://dx.doi.org/10.3390/ijms23020633.
Pełny tekst źródłaTarlock, Katherine, Todd M. Cooper, Todd A. Alonzo, Robert Gerbing, Jessica Pollard, Richard Aplenc, E. Anders Kolb, Alan S. Gamis i Soheil Meshinchi. "Mutational Concordance from Diagnosis and Relapse in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group". Blood 128, nr 22 (2.12.2016): 2846. http://dx.doi.org/10.1182/blood.v128.22.2846.2846.
Pełny tekst źródłaShang, Yanhong, Hao Zhang, Aiming Zang, Shaohua Yuan, Xiaofang Li, Wenpan Zhang, Ran Huo i in. "Abstract 5754: The molecular characteristics of EGFR co-mutations in lung adenocarcinoma". Cancer Research 82, nr 12_Supplement (15.06.2022): 5754. http://dx.doi.org/10.1158/1538-7445.am2022-5754.
Pełny tekst źródłaKapoor, Ritika R., Sarah E. Flanagan, Piers Fulton, Anupam Chakrapani, Bernadette Chadefaux, Tawfeg Ben-Omran, Indraneel Banerjee, Julian P. Shield, Sian Ellard i Khalid Hussain. "Hyperinsulinism–hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype–phenotype correlations". European Journal of Endocrinology 161, nr 5 (listopad 2009): 731–35. http://dx.doi.org/10.1530/eje-09-0615.
Pełny tekst źródłaBalamurugan, Kuppareddi, Martin L. Tracey, Uwe Heine, George C. Maha i George T. Duncan. "Mutation at the Human D1S80 Minisatellite Locus". Scientific World Journal 2012 (2012): 1–8. http://dx.doi.org/10.1100/2012/917235.
Pełny tekst źródłaClaes, Kathleen, Eva Machackova, Michel De Vos, Bruce Poppe, Anne De Paepe i Ludwine Messiaen. "Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G". Disease Markers 15, nr 1-3 (1999): 69–73. http://dx.doi.org/10.1155/1999/241046.
Pełny tekst źródłaWood, Anthony C., Yonghong Zhang, Qianxing Mo, Ling Cen, Jacques Fontaine, Sarah E. Hoffe, Jessica Frakes i in. "Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status". Oncologist 27, nr 4 (26.02.2022): 307–13. http://dx.doi.org/10.1093/oncolo/oyac018.
Pełny tekst źródłaAhn, Jae-Sook, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, Il-Kwon Lee, Nan Young Kim, Mark D. Minden, Chul Won Jung i in. "An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype". Blood 124, nr 21 (6.12.2014): 1052. http://dx.doi.org/10.1182/blood.v124.21.1052.1052.
Pełny tekst źródłaKang, S., S. S. Seo, H. J. Chang, C. W. Yoo, S. Y. Park i S. M. Dong. "Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma". International Journal of Gynecologic Cancer 18, nr 6 (2008): 1339–43. http://dx.doi.org/10.1111/j.1525-1438.2007.01172.x.
Pełny tekst źródłaFRY, JAMES D. "Rapid mutational declines of viability in Drosophila". Genetical Research 77, nr 1 (luty 2001): 53–60. http://dx.doi.org/10.1017/s0016672300004882.
Pełny tekst źródłaDelaugerre, Constance, Mireille Mouroux, Anne Yvon-Groussin, Anne Simon, Francis Angleraud, Jean-Marie Huraux, Henri Agut, Christine Katlama i Vincent Calvez. "Prevalence and Conditions of Selection of E44D/A and V118I Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations in Clinical Practice". Antimicrobial Agents and Chemotherapy 45, nr 3 (1.03.2001): 946–48. http://dx.doi.org/10.1128/aac.45.3.946-948.2001.
Pełny tekst źródłaGolding, G. Brian, Patricia J. Gearhart i Barry W. Glickman. "Patterns of Somatic Mutations in Immunoglobulin Variable Genes". Genetics 115, nr 1 (1.01.1987): 169–76. http://dx.doi.org/10.1093/genetics/115.1.169.
Pełny tekst źródłaDunson, David B., i Kenneth R. Tindall. "Bayesian Analysis of Mutational Spectra". Genetics 156, nr 3 (1.11.2000): 1411–18. http://dx.doi.org/10.1093/genetics/156.3.1411.
Pełny tekst źródłaAstudillo, H., J. Sanchez-Guillen, P. Romero-Garcia, J. Bastarrachea-ortiz, G. Morgan-Villela, J. M. Salazar, V. M. Vazquez-Rivera, H. Ruiz-Calzada i P. Cortes-Esteban. "Polymorphism detection of K-Ras mutations using high-resolution melting analysis in Mexican patients with metastatic colorectal cancer (mCRC)". Journal of Clinical Oncology 27, nr 15_suppl (20.05.2009): e15135-e15135. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e15135.
Pełny tekst źródłaPiombino, Claudia, Angela Toss, Alessandra Bologna, Elisa Gasparini, Vittoria Tarantino, Maria Elisabetta Filieri, Luca Cottafavi i in. "The prognostic role of somatic BRCA mutations in ovarian cancer: Preliminary results from an observational multicenter cohort study." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e13674-e13674. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13674.
Pełny tekst źródłaKuang, Shelley, Sally C. M. Lau, Kieran Sharma, Juehea Lee, Malcolm Isaiah Ryan, Sabine Schmid, Penelope Ann Bradbury i in. "Impact of KRAS mutational variant on response to immunotherapy in metastatic NSCLC." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): e21127-e21127. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e21127.
Pełny tekst źródłaBorowczyk, Martyna, Ewelina Szczepanek-Parulska, Szymon Dębicki, Bartłomiej Budny, Małgorzata Janicka-Jedyńska, Lidia Gil, Frederik A. Verburg i in. "High incidence of FLT3 mutations in follicular thyroid cancer: potential therapeutic target in patients with advanced disease stage". Therapeutic Advances in Medical Oncology 12 (styczeń 2020): 175883592090753. http://dx.doi.org/10.1177/1758835920907534.
Pełny tekst źródłaMachado, Heather E., Nina Friesgaard Øbro, Emily Mitchell, Megan Davies, Anthony R. Green, Kourosh Saeb-Parsy, Daniel James Hodson, David Kent i Peter J. Campbell. "Life History of Normal Human Lymphocytes Revealed By Somatic Mutations". Blood 134, Supplement_1 (13.11.2019): 1045. http://dx.doi.org/10.1182/blood-2019-128188.
Pełny tekst źródłaZeineddine, Fadl, Benjamin Garmezy, Timothy A. Yap i John Paul Y. C. Shen. "PMC: A more precise classifier of POLE mutations to identify candidates for immune therapy." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): 3548. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3548.
Pełny tekst źródłaStratton, Michael R. "Abstract PL02-01: The pathogenesis of cancer susceptibility due to inherited DNA repair defects". Cancer Research 82, nr 12_Supplement (15.06.2022): PL02–01—PL02–01. http://dx.doi.org/10.1158/1538-7445.am2022-pl02-01.
Pełny tekst źródłaJaffar, Nazish, Shahnaz Imdad Kehar, Aliya Zaman, Saadia Akram i Kiran Abbas. "Spectrum of Tp53 gene mutation in basal cell carcinoma and its morphological subtypes in people of color." Professional Medical Journal 26, nr 10 (10.10.2019): 1783–88. http://dx.doi.org/10.29309/tpmj/2019.26.10.4141.
Pełny tekst źródłaLee, Ye Ji, Yejin Lee, Youn Jung Kim, Zang Hee Lee i Jung-Wook Kim. "Novel PAX9 Mutations Causing Isolated Oligodontia". Journal of Personalized Medicine 14, nr 2 (8.02.2024): 191. http://dx.doi.org/10.3390/jpm14020191.
Pełny tekst źródłaJeffers, Michael, Christian Kappeler, Iris Kuss, Georg Beckmann, Daniel H. Mehnert, Johannes Fredebohm i Michael Teufel. "Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial". Gastric Cancer 25, nr 3 (20.01.2022): 598–608. http://dx.doi.org/10.1007/s10120-021-01274-6.
Pełny tekst źródłaXu, Hong-Tao, Maureen Oliveira, Peter K. Quashie, Matthew McCallum, Yingshan Han, Yudong Quan, Bluma G. Brenner i Mark A. Wainberg. "Subunit-Selective Mutational Analysis and Tissue Culture Evaluations of the Interactions of the E138K and M184I Mutations in HIV-1 Reverse Transcriptase". Journal of Virology 86, nr 16 (23.05.2012): 8422–31. http://dx.doi.org/10.1128/jvi.00271-12.
Pełny tekst źródłaJuriloff, D. M., S. D. Porter i M. J. Harris. "Three spontaneous mutations at the albino locus in SELH/Bc mice". Genome 37, nr 2 (1.04.1994): 190–97. http://dx.doi.org/10.1139/g94-026.
Pełny tekst źródłaMaldonado, J. Alberto, Chin-Hsien Tai i Christine Alewine. "Genomic characterization of somatic mutations by race and ethnicity in pancreatic cancer defined through AACR project GENIE." Journal of Clinical Oncology 41, nr 16_suppl (1.06.2023): 4138. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.4138.
Pełny tekst źródłaWiens, G. D., K. A. Heldwein, M. P. Stenzel-Poore i M. B. Rittenberg. "Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion." Journal of Immunology 159, nr 3 (1.08.1997): 1293–302. http://dx.doi.org/10.4049/jimmunol.159.3.1293.
Pełny tekst źródłaLin, Selena Y., Ting-Tsung Chang, Jamin D. Steffen, Sitong Chen, Surbhi Jain, Wei Song, Yih-Jyh Lin i Ying-Hsiu Su. "Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients". Diagnostics 11, nr 8 (14.08.2021): 1475. http://dx.doi.org/10.3390/diagnostics11081475.
Pełny tekst źródłaPatterson, Andrew, Abdurrahman Elbasir, Bin Tian i Noam Auslander. "Computational Methods Summarizing Mutational Patterns in Cancer: Promise and Limitations for Clinical Applications". Cancers 15, nr 7 (24.03.2023): 1958. http://dx.doi.org/10.3390/cancers15071958.
Pełny tekst źródłaLyons, Daniel, i Adam Lauring. "Mutation and Epistasis in Influenza Virus Evolution". Viruses 10, nr 8 (3.08.2018): 407. http://dx.doi.org/10.3390/v10080407.
Pełny tekst źródłaHwang, Tae Sook, Wook Youn Kim, Hye Seung Han, So Dug Lim, Wan-Seop Kim, Young Bum Yoo, Kyoung Sik Park, Seo Young Oh, Suk Kyeong Kim i Jung Hyun Yang. "Preoperative RAS Mutational Analysis Is of Great Value in Predicting Follicular Variant of Papillary Thyroid Carcinoma". BioMed Research International 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/697068.
Pełny tekst źródłaThomas, Renjan, Gautam Balaram, Hrishi Varayathu, Suhas N. Ghorpade, Prarthana V. Kowsik, Baby Dharman, Beulah Elsa Thomas i in. "Molecular epidemiology and clinical characteristics of epidermal growth factor receptor mutations in NSCLC: A single-center experience from India". Journal of Cancer Research and Therapeutics 19, nr 5 (2023): 1398–406. http://dx.doi.org/10.4103/jcrt.jcrt_1986_21.
Pełny tekst źródłaIto-Harashima, Sayoko, Phillip E. Hartzog, Himanshu Sinha i John H. McCusker. "The tRNA-Tyr Gene Family ofSaccharomyces cerevisiae: Agents of Phenotypic Variation and Position Effects on Mutation Frequency". Genetics 161, nr 4 (1.08.2002): 1395–410. http://dx.doi.org/10.1093/genetics/161.4.1395.
Pełny tekst źródłaKeightley, Peter D., i Ohmi Ohnishi. "EMS-Induced Polygenic Mutation Rates for Nine Quantitative Characters in Drosophila melanogaster". Genetics 148, nr 2 (1.02.1998): 753–66. http://dx.doi.org/10.1093/genetics/148.2.753.
Pełny tekst źródłaAlohali, Sama, Alexandra E. Payne, Marc Pusztaszeri, Mohannad Rajab, Véronique-Isabelle Forest, Michael P. Hier, Michael Tamilia i Richard J. Payne. "Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations". Cancers 15, nr 2 (8.01.2023): 413. http://dx.doi.org/10.3390/cancers15020413.
Pełny tekst źródłaLi, Hongxia, Qianqian Duan i Yuan Tan. "Somatic and germline mutation profiles of Chinese young colorectal cancer patients." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): e15522-e15522. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e15522.
Pełny tekst źródłaHa, Jung Sook, Jae Hee Lee, Sung Gyun Park, Nam Hee Ryoo, Dong Suk Jeon, Jae Ryong Kim, Young Rok Do i in. "Correlations Between TET2 Mutation and Clinicohematologic Parameters in Myeloproliferative Neoplasms". Blood 120, nr 21 (16.11.2012): 1455. http://dx.doi.org/10.1182/blood.v120.21.1455.1455.
Pełny tekst źródłaMüller, Martin C., Jorge Cortes, Dong-Wook Kim, Brian J. Druker, Philipp Erben, Ricardo Pasquini, Timothy P. Hughes, Yousif Matloub, Lynn Ploughman i Andreas Hochhaus. "Dasatinib Efficacy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Pre-Existing BCR-ABL Mutations". Blood 112, nr 11 (16.11.2008): 449. http://dx.doi.org/10.1182/blood.v112.11.449.449.
Pełny tekst źródłaHughes, Timothy, Giuseppe Saglio, Giovanni Martinelli, Dong-Wook Kim, S. Soverini, Martin Mueller, A. Haque i in. "Responses and Disease Progression in CML-CP Patients Treated with Nilotinib after Imatinib Failure Appear To Be Affected by the BCR-ABL Mutation Status and Types." Blood 110, nr 11 (16.11.2007): 320. http://dx.doi.org/10.1182/blood.v110.11.320.320.
Pełny tekst źródła